研究者
J-GLOBAL ID：201801015479230663   更新日: 2021年10月22日

加藤 順也

Kato Jun'ya
所属機関・部署：
奈良先端科学技術大学院大学

奈良先端科学技術大学院大学 について


研究分野 (1件)： 腫瘍生物学
論文 (43件)：
  • Ikuko Nakamae, Tsumoru Morimoto, Hiroki Shima, Masafumi Shionyu, Hisayo Fujiki, Noriko Yoneda-Kato, Takashi Yokoyama, Shigehiko Kanaya, Kiyomi Kakiuchi, Tsuyoshi Shirai, et al. Curcumin Derivatives Verify the Essentiality of ROS Upregulation in Tumor Suppression. Molecules (Basel, Switzerland). 2019. 24. 22
  • Beni Lestari, Ikuko Nakamae, Noriko Yoneda-Kato, Tsumoru Morimoto, Shigehiko Kanaya, Takashi Yokoyama, Masafumi Shionyu, Tsuyoshi Shirai, Edy Meiyanto, Jun-Ya Kato. Pentagamavunon-1 (PGV-1) inhibits ROS metabolic enzymes and suppresses tumor cell growth by inducing M phase (prometaphase) arrest and cell senescence. Scientific reports. 2019. 9. 1. 14867-14867
  • Edy Meiyanto, Herwandhani Putri, Yonika Arum Larasati, Rohmad Yudi Utomo, Riris Istighfari Jenie, Muthi Ikawati, Beni Lestari, Noriko Yoneda-Kato, Ikuko Nakamae, Masashi Kawaichi, et al. Anti-proliferative and Anti-metastatic Potential of Curcumin Analogue, Pentagamavunon-1 (PGV-1), Toward Highly Metastatic Breast Cancer Cells in Correlation with ROS Generation. Advanced pharmaceutical bulletin. 2019. 9. 3. 445-452
  • Riris Istighfari Jenie, Nur Dina Amalina, Gagas Pradani Nur Ilmawati, Rohmad Yudi Utomo, Muthi Ikawati, Annisa Khumaira, Jun-Ya Kato, Edy Meiyanto. Cell Cycle Modulation of CHO-K1 Cells Under Genistein Treatment Correlates with Cells Senescence, Apoptosis and ROS Level but in a Dose-Dependent Manner. Advanced pharmaceutical bulletin. 2019. 9. 3. 453-461
  • Larasati YA, Yoneda-Kato N, Nakamae I, Yokoyama T, Meiyanto E, Kato JY. Curcumin targets multiple enzymes involved in the ROS metabolic pathway to suppress tumor cell growth. Scientific reports. 2018. 8. 1. 2039-2039
もっと見る
MISC (7件)：
もっと見る
特許 (5件)：
※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。 登録・更新については、こちらをご覧ください。

前のページに戻る

TOP

BOTTOM